Literature DB >> 24065372

p53 pathway activation by telomere attrition in X-DC primary fibroblasts occurs in the absence of ribosome biogenesis failure and as a consequence of DNA damage.

J Carrillo1, A González, C Manguán-García, L Pintado-Berninches, R Perona.   

Abstract

BACKGROUND: Dyskeratosis congenita (DC) is a rare inherited bone marrow failure syndrome with high clinical heterogeneity. Various mutations have been reported in DC patients, affecting genes that code for components of H/ACA ribonucleoproteins, proteins of the telomerase complex and components of the shelterin complex.
OBJECTIVES: We aim to clarify the role of ribosome biogenesis failure in senescence induction in X-DC since some studies in animal models have reported a decrease in ribosome biogenesis as a major role in the disease.
METHODS: Dyskerin was depleted in normal human fibroblasts by expressing two DKC1 shRNAs. Common changes in gene expression profile between these dyskerin-depleted cells and X-DC fibroblasts were analyzed.
RESULTS: Dyskerin depletion induced early activation of the p53 pathway probably secondary to ribosome biogenesis failure. However, the p53 pathway in the fibroblasts from X-DC patients was activated only after an equivalent number of passes to AD-DC fibroblasts, in which telomere attrition in each division rendered shorter telomeres than control fibroblasts. Indeed, no induction of DNA damage was observed in dyskerin-depleted fibroblasts in contrast to X-DC or AD-DC fibroblasts suggesting that DNA damage induced by telomere attrition is responsible for p53 activation in X-DC and AD-DC fibroblasts. Moreover, p53 depletion in senescent DC fibroblasts rescued their proliferative capacity and reverted the morphological changes produced after prolonged culture.
CONCLUSIONS: Our data indicate that ribosome biogenesis do not seem to play an important role in dyskeratosis congenita, conversely increasing DNA damage and activation of p53 pathway triggered by telomere shortening is the main activator of cell senescence.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24065372     DOI: 10.1007/s12094-013-1112-3

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  23 in total

Review 1.  Functional links between telomeres and proteins of the DNA-damage response.

Authors:  Fabrizio d'Adda di Fagagna; Soo-Hwang Teo; Stephen P Jackson
Journal:  Genes Dev       Date:  2004-08-01       Impact factor: 11.361

2.  Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.

Authors:  Tom Vulliamy; Anna Marrone; Richard Szydlo; Amanda Walne; Philip J Mason; Inderjeet Dokal
Journal:  Nat Genet       Date:  2004-04-18       Impact factor: 38.330

3.  Clinical utility gene card for: dyskeratosis congenita.

Authors:  Inderjeet Dokal; Tom Vulliamy; Philip Mason; Monica Bessler
Journal:  Eur J Hum Genet       Date:  2011-05-25       Impact factor: 4.246

4.  X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions.

Authors:  N S Heiss; S W Knight; T J Vulliamy; S M Klauck; S Wiemann; P J Mason; A Poustka; I Dokal
Journal:  Nat Genet       Date:  1998-05       Impact factor: 38.330

5.  The p53/p21(WAF/CIP) pathway mediates oxidative stress and senescence in dyskeratosis congenita cells with telomerase insufficiency.

Authors:  Erik R Westin; Nukhet Aykin-Burns; Erin M Buckingham; Douglas R Spitz; Frederick D Goldman; Aloysius J Klingelhutz
Journal:  Antioxid Redox Signal       Date:  2011-01-17       Impact factor: 8.401

6.  Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita.

Authors:  Judy M Y Wong; Mouhammed J Kyasa; Laura Hutchins; Kathleen Collins
Journal:  Hum Genet       Date:  2004-09-03       Impact factor: 4.132

7.  Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita.

Authors:  Tom Vulliamy; Richard Beswick; Michael Kirwan; Anna Marrone; Martin Digweed; Amanda Walne; Inderjeet Dokal
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-03       Impact factor: 11.205

8.  Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification.

Authors:  Davide Ruggero; Silvia Grisendi; Francesco Piazza; Eduardo Rego; Francesca Mari; Pulivarthi H Rao; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  Science       Date:  2003-01-10       Impact factor: 47.728

9.  A dyskerin motif reactivates telomerase activity in X-linked dyskeratosis congenita and in telomerase-deficient human cells.

Authors:  Rosario Machado-Pinilla; Isabel Sánchez-Pérez; José Ramón Murguía; Leandro Sastre; Rosario Perona
Journal:  Blood       Date:  2007-12-05       Impact factor: 22.113

10.  Zebrafish models for dyskeratosis congenita reveal critical roles of p53 activation contributing to hematopoietic defects through RNA processing.

Authors:  Ying Zhang; Kenji Morimoto; Nadia Danilova; Bo Zhang; Shuo Lin
Journal:  PLoS One       Date:  2012-01-27       Impact factor: 3.240

View more
  11 in total

1.  Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita.

Authors:  Hemanth Tummala; Amanda Walne; Laura Collopy; Shirleny Cardoso; Josu de la Fuente; Sarah Lawson; James Powell; Nicola Cooper; Alison Foster; Shehla Mohammed; Vincent Plagnol; Thomas Vulliamy; Inderjeet Dokal
Journal:  J Clin Invest       Date:  2015-04-20       Impact factor: 14.808

Review 2.  Unraveling the pathogenesis of Hoyeraal-Hreidarsson syndrome, a complex telomere biology disorder.

Authors:  Galina Glousker; Fabien Touzot; Patrick Revy; Yehuda Tzfati; Sharon A Savage
Journal:  Br J Haematol       Date:  2015-05-04       Impact factor: 6.998

3.  Ribosomal Protein Mutations Result in Constitutive p53 Protein Degradation through Impairment of the AKT Pathway.

Authors:  Ana T Antunes; Yvonne J Goos; Tamara C Pereboom; Dorien Hermkens; Marcin W Wlodarski; Lydie Da Costa; Alyson W MacInnes
Journal:  PLoS Genet       Date:  2015-07-01       Impact factor: 5.917

4.  Expression of the genetic suppressor element 24.2 (GSE24.2) decreases DNA damage and oxidative stress in X-linked dyskeratosis congenita cells.

Authors:  Cristina Manguan-Garcia; Laura Pintado-Berninches; Jaime Carrillo; Rosario Machado-Pinilla; Leandro Sastre; Carme Pérez-Quilis; Isabel Esmoris; Amparo Gimeno; Jose Luis García-Giménez; Federico V Pallardó; Rosario Perona
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

Review 5.  Impaired ribosome biogenesis: mechanisms and relevance to cancer and aging.

Authors:  Zsofia Turi; Matthew Lacey; Martin Mistrik; Pavel Moudry
Journal:  Aging (Albany NY)       Date:  2019-04-26       Impact factor: 5.682

Review 6.  Peering through zebrafish to understand inherited bone marrow failure syndromes.

Authors:  Usua Oyarbide; Jacek Topczewski; Seth J Corey
Journal:  Haematologica       Date:  2018-12-20       Impact factor: 9.941

Review 7.  The diagnosis and treatment of dyskeratosis congenita: a review.

Authors:  M Soledad Fernández García; Julie Teruya-Feldstein
Journal:  J Blood Med       Date:  2014-08-21

8.  Identification of hub genes of pneumocyte senescence induced by thoracic irradiation using weighted gene co‑expression network analysis.

Authors:  Yonghua Xing; Junling Zhang; Lu Lu; Deguan Li; Yueying Wang; Song Huang; Chengcheng Li; Zhubo Zhang; Jianguo Li; Aimin Meng
Journal:  Mol Med Rep       Date:  2015-11-13       Impact factor: 2.952

9.  GSE4, a Small Dyskerin- and GSE24.2-Related Peptide, Induces Telomerase Activity, Cell Proliferation and Reduces DNA Damage, Oxidative Stress and Cell Senescence in Dyskerin Mutant Cells.

Authors:  Laura Iarriccio; Cristina Manguán-García; Laura Pintado-Berninches; José Miguel Mancheño; Antonio Molina; Rosario Perona; Leandro Sastre
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

10.  Acute telomerase components depletion triggers oxidative stress as an early event previous to telomeric shortening.

Authors:  José Santiago Ibáñez-Cabellos; Giselle Pérez-Machado; Marta Seco-Cervera; Ester Berenguer-Pascual; José Luis García-Giménez; Federico V Pallardó
Journal:  Redox Biol       Date:  2017-10-07       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.